Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.24.1.u1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Concentration Risk [Line Items]    
Revenues $ 78,025 $ 72,162
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 51,990 53,190
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 26,035 $ 18,972